InvestSMART

CSL Limited (ASX: CSL) - Announcements

- Current share price for CSL : $171.570

ASX company news and announcements for CSL Limited (CSL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All CSL Limited (CSL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than CSL Limited (CSL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for CSL Limited (CSL)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$82,334 Notification regarding unquoted securities - CSL 18 Feb 2026 4:21PM $152.740 $171.570 risen by 12.33%
$82,334 Update - Notification of buy-back - CSL 18 Feb 2026 8:16AM $151.560 $171.570 risen by 13.20%
$82,334 CSL and Lilly enter Licensing Agreement for clazakizumab 18 Feb 2026 8:13AM $151.560 $171.570 risen by 13.20%
$82,334 Update - Notification of buy-back - CSL 17 Feb 2026 8:10AM $152.170 $171.570 risen by 12.75%
$82,334 Update - Notification of buy-back - CSL 16 Feb 2026 8:23AM $150.010 $171.570 risen by 14.37%
$82,334 Update - Notification of buy-back - CSL 16 Feb 2026 8:14AM $150.010 $171.570 risen by 14.37%
$82,334 Final Director's Interest Notice 11 Feb 2026 2:00PM $160.400 $171.570 risen by 6.96%
$82,334 CSL Half Year Results Investor Presentation 11 Feb 2026 7:46AM $171.390 $171.570 risen by 0.11%
$82,334 Dividend/Distribution - CSL 11 Feb 2026 7:43AM $171.390 $171.570 risen by 0.11%
$82,334 CSL Half Year Results Announcement 11 Feb 2026 7:41AM $171.390 $171.570 risen by 0.11%
$82,334 CSL Statutory Accounts for the Half Year Ended 31 December 11 Feb 2026 7:41AM $171.390 $171.570 risen by 0.11%
$82,334 Paul McKenzie retires, Gordon Naylor appointed interim CEO 10 Feb 2026 4:05PM $183.640 $171.570 fallen by 6.57%
$82,334 Notification of cessation of securities - CSL 6 Feb 2026 2:07PM $181.060 $171.570 fallen by 5.24%
$82,334 Notice of HY26 results release and briefing 2 Feb 2026 8:21AM $181.420 $171.570 fallen by 5.43%
$82,334 Change in substantial holding 29 Jan 2026 8:18AM $180.190 $171.570 fallen by 4.78%
$82,334 Notification of cessation of securities - CSL 9 Jan 2026 10:47AM $173.890 $171.570 fallen by 1.33%
$82,334 Update - Notification of buy-back - CSL 18 Dec 2025 8:25AM $173.390 $171.570 fallen by 1.05%
$82,334 Update - Notification of buy-back - CSL 17 Dec 2025 8:26AM $177.150 $171.570 fallen by 3.15%
$82,334 Update - Notification of buy-back - CSL 16 Dec 2025 8:21AM $179.310 $171.570 fallen by 4.32%
$82,334 Update - Notification of buy-back - CSL 15 Dec 2025 8:22AM $183.930 $171.570 fallen by 6.72%
$82,334 Update - Notification of buy-back - CSL 12 Dec 2025 8:24AM $178.810 $171.570 fallen by 4.05%
$82,334 Update - Notification of buy-back - CSL 11 Dec 2025 8:18AM $181.630 $171.570 fallen by 5.54%
$82,334 Update - Notification of buy-back - CSL 10 Dec 2025 8:27AM $181.820 $171.570 fallen by 5.64%
$82,334 Update - Notification of buy-back - CSL 9 Dec 2025 8:23AM $185.500 $171.570 fallen by 7.51%
$82,334 Update - Notification of buy-back - CSL 8 Dec 2025 8:33AM $184.100 $171.570 fallen by 6.81%

101 - 125 of 1181 results

Page 5 of 48

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.